Sophia Genetics

Sophia Genetics, founded in 2011, has developed a software platform capable of diagnosing patients' conditions by analyzing genetic data. Its product, "Sophia," powered by artificial intelligence, is now used by 330 hospitals across 53 countries, diagnosing 8,000 patients each month. It provides a cloud-based Software-as-a-Service platform — the SOPHiA DDM™ platform — enabling healthcare institutions to gain fast and reliable insights from their data. Our technology is applied to diseases such as cancer and genetic disorders, where integrating genomic and phenotypic information is crucial for supporting discovery, treatment decisions, and drug development efforts.